does semaglutide lower your a1c Avono Health | GLP-1 Explained: vs tirzepatide, broken down with the actual clinical trial data: how they work, weight loss, side effects, and Semaglutide (GLP-1 receptor agonist) medications

The Nutrition Connection As a registered dietitian, Sarah emphasizes that GLP-1s arent a magic bullet

Signs that weed might be slowing your GLP-1 progress include: Snacking out of habit instead of hunger Edibles becoming a nightly routine rather than an occasional choice Eating past fullness because munchies feel mental, not physical Mindful use tends to coexist just fine with GLP-1 goals, especially when youre aware of delayed edible effects and appetite signals

For users who are interested in the comparison between these two GLP-1 agents, our dedicated Brello Health tirzepatide review covers the tirzepatide offering in detail

Two commonly researched GHSs are CJC-1295 (with or without DAC) and Ipamorelin

Why Blood Sugar May Not Be Very High In classic DKA: Insulin deficiency severe hyperglycemia In euglycemic DKA: Some insulin is still being administered Blood glucose may appear only mildly elevated But insulin is insufficient to prevent ketogenesis This can delay recognition because: Patients and clinicians may not suspect DKA with glucose under 250 mg/dL Symptoms may initially resemble dehydration or GI illness Additional Contributing Factors GLP-1 use in Type 1 diabetes may also increase DKA risk due to: Vomiting dehydration stress hormones ketone rise Intentional insulin reduction due to fear of hypoglycemia Reduced basal insulin during weight loss Increased glycemic variability from delayed gastric emptying Hypoglycemia and the Insulin Reduction Trap Another issue is the cycle that can develop: Appetite decreases Insulin dose is reduced Hypoglycemia occurs intermittently Insulin is reduced further Ketone production increases Over time, this can push the patient into metabolic instability